Barnik Invest Launches Cell4Cure AB to Advance Innovative Immunotherapy

Stockholm, Sweden – Barnik Invest Group is pleased to announce the official launch of Cell4Cure AB, a new company focused on developing advanced therapies based on antigen-specific dendritic cell mediated tolerance. This innovative approach aims to treat diseases where the immune system attacks the body’s own tissues. A consortium of former Idogen board members, together […]